BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7201947)

  • 1. [Tumor reduction by second-look laparotomy following combined radiochemotherapy in advanced ovarian carcinoma].
    Szalay S; Janisch H; Breitenecker G; Szepesi T
    Gynakol Rundsch; 1982; 22(2):150-3. PubMed ID: 7201947
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
    Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of epithelial carcinoma of the ovary.
    Zucker PK; Rosenshein NB
    Compr Ther; 1985 May; 11(5):52-9. PubMed ID: 4006423
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual site of recurrence in epithelial ovarian carcinoma: Intercostal space metastasis.
    Deffieux X; Eldweny H; Pocard M; Morice P
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):264-5. PubMed ID: 16459013
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Time factor in the second-look operation following chemotherapy and radiotherapy of advanced epithelial ovarian carcinoma. Considerations on tumor cell kinetics].
    Szepesi T; Kärcher KH; Kogelnik HD; Janisch H; Szalay S; Breitenecker G
    Gynakol Rundsch; 1982; 22(2):154-7. PubMed ID: 7201948
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of recurrent disease after a negative second look laparotomy.
    Ayhan A; Gultekin M; Dursun P; Dogan NU; Aksan G; Guven S; Yuce K
    J Surg Oncol; 2008 Mar; 97(3):226-30. PubMed ID: 18050284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Times and sites of relapses after negative second look in advanced epithelial ovarian cancer.
    Maggino T; Gadducci A; Romagnolo C; Fanucchi A; Fioretti P
    Eur J Surg Oncol; 1994 Apr; 20(2):146-50. PubMed ID: 8181580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinoma in three teen-age siblings.
    McCrann DJ; Marchant DJ; Bardawil WA
    Obstet Gynecol; 1974 Jan; 43(1):132-7. PubMed ID: 4808954
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.
    Senapad S; Neungton S; Thirapakawong C; Suphanit I; Hangsubcharoen M; Thamintorn K
    Anticancer Res; 2000; 20(2B):1297-300. PubMed ID: 10810438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in the treatment of ovarian carcinoma].
    Pfisterer J; du Bois A; Hilpert F; Wagner U; Meier W
    Dtsch Med Wochenschr; 2004 Feb; 129(8):379-84. PubMed ID: 14961446
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
    Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
    Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New approaches to the treatment of advanced ovarian cancer].
    Ivanov S
    Akush Ginekol (Sofiia); 2006; 45(4):20-3. PubMed ID: 16889195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of P-32 in stage III epithelial carcinoma of the ovary.
    Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
    Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of laparoscopy in ovarian carcinoma].
    Angioli R; Muzii L; Battista C; Terranova C; Oronzi I; Sereni MI; De Oronzo MA; Damiani P; Collettini F; Graziano M; Benedetti Panici P
    Minerva Ginecol; 2009 Feb; 61(1):35-43. PubMed ID: 19204659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery of primary cancers of the ovary].
    Bobin JY
    Rev Prat; 1997 Jun; 47(11):1199-203. PubMed ID: 9238815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
    Tarraza HM; Boyce CR; Smith WG; Jones MA
    Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.